LEP and obesity due to melanocortin 4 receptor deficiency: Our findings provide the first evidence that the anti-obesity effects of MED are attributable to the regulation of multiple targets associated with lipid metabolism, including lipid accumulation, lipolysis, the inflammasome, cytokine expression, and the expressions of related signaling molecules in Lep knockout mice.